About
Simulations Plus Inc (NASDAQ:SLP) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Apr 20 2026
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
Apr 9 2026
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results
Mar 26 2026
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
Mar 26 2026
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling
Financials
Revenue
$78.68 M
Market Cap
$241.56 M
EPS
-3.20
Google Übersetzer